UMOOZE and the Synergy of Astragalus and Soybean

BPH is a common condition in men in which the prostate enlarges that tends to increase with age and causes urinary tract symptoms that affect quality of life, usually after age 40. Incidence
increases with age in almost all men by the time they reach their 80s, but BPH does not require treatment unless the symptoms require treatment. Prostate enlargement can lead to obstruction
of the bladder, making it difficult to urinate. Common symptoms include urinary incontinence, hesitation, frequency, weak flow, decreased void volume, dysuria, nocturia, straining, prolonged flow and complete or partial urinary retention.
While BPH is often not malignant, it can affect a man’s quality of life. The goal of any BPH treatment should be to slow the progression of BPH while improving a man’s quality of life. Since every case is different, treatment options should be discussed with your physician based on symptoms and condition to decide which course of action is right for you.
UMOOZE®
UMOOZE® is an add-on therapy taken twice a day to help improve the symptoms of BPH which are measured by the International Prostate Symptom Score (IPSS) and Quality of Life (QoL) index. UMOOZE® contains astragalus extracts and soy isoflavones. Astragalus extracts and soybean extracts are combined into one 500 mg UMOOZE® tablet, and it is considered a food supplement, dietary supplement, or nutraceutical. Astragalus is a dried root commonly used in traditional Chinese medicine and has been used as such for about 4,000 years. And according to the National Cancer Institute of America, people who consume soybean products can reduce their risk of developing prostate cancer.
UMOOZE® was designed to support the symptoms of BPH. In one study, it was administered as an add-on therapy for 56 consecutive days to men with a history of this medical condition. The objective of this study was to evaluate the benefits of UMOOZE® as an add-on therapy against BPH by evaluating the improvements in symptoms, as measured by the individual’s IPSS and QoL index.
Results measured at different stages showed that UMOOZE® improved the overall IPSS for nocturia and LUTS (Lower Urinary Tract Symptoms) while improving the patient’s quality of life (QoL). The Post-Void Residual (PVR) urine volume was decreased and the prostate volume in patients with BPH was reduced. UMOOZE® has proven to be well tolerated and helpful as anadd-on therapy and offers many health benefits in managing BPH successfully.
Are you a health conscious person? You may enjoy reading questions and answers I write about health. For more information about prostate health, please read my free eBook. And for anything you want to consult, I invite you to connect with yours truly, Dr. Susana.